Narjust Florez MD, FASCO

Dr. Narjust Florez, MD, FASCO, is the Associate Medical Director of the Cancer Care Access Program and a thoracic medical oncologist at the Dana-Farber Brigham Cancer Center. She completed her internal medicine residency at Rutgers New Jersey Medical School and her fellowship at the Mayo Clinic in Rochester, Minnesota, where she served as chief fellow from 2018 to 2019. Dr. Florez's clinical interests include targeted therapy for lung cancer and the care of women with lung cancer, including their unique aspects of cancer survivorship. She is the principal investigator of the Sexual Health Assessment in Women with Lung Cancer (SHAWL) Study, the largest study to date evaluating sexual dysfunction in women with lung cancer.

Apart from her clinical interests in lung cancer, she is also a leading and productive researcher in cancer health disparities, gender and racial discrimination in medical education and medicine. She received many awards, including the 2018 Resident of the Year Award from the National Hispanic Medical Association, the Mayo Brothers Distinguished Fellowship Award, and the 2020 Rising Star Award from the LEAD national conference for women in hematology and oncology. In addition, Dr. Florez founded the Florez Lab in 2019. The laboratory focuses on lung cancer, social justice issues in medicine, and medical education. The laboratory's long-term goals are to create a welcoming environment for medical trainees from historically underrepresented groups in medicine while improving the care of vulnerable populations. Members of the Florez Lab are agents of change.